210 related articles for article (PubMed ID: 23229173)
1. Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC.
Salvi A; Abeni E; Portolani N; Barlati S; De Petro G
Int J Oncol; 2013 Feb; 42(2):391-402. PubMed ID: 23229173
[TBL] [Abstract][Full Text] [Related]
2. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
3. Identifying Differentially Expressed MicroRNAs Between Cirrhotic and Non-Cirrhotic Hepatocellular Carcinoma and Exploring Their Functions Using Bioinformatic Analysis.
Mei Y; You Y; Xia J; Gong JP; Wang YB
Cell Physiol Biochem; 2018; 48(4):1443-1456. PubMed ID: 30064138
[TBL] [Abstract][Full Text] [Related]
4. Effects of miR-193a and sorafenib on hepatocellular carcinoma cells.
Salvi A; Conde I; Abeni E; Arici B; Grossi I; Specchia C; Portolani N; Barlati S; De Petro G
Mol Cancer; 2013 Dec; 12():162. PubMed ID: 24330766
[TBL] [Abstract][Full Text] [Related]
5. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM
Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma.
Jin Y; Wong YS; Goh BKP; Chan CY; Cheow PC; Chow PKH; Lim TKH; Goh GBB; Krishnamoorthy TL; Kumar R; Ng TP; Chong SS; Tan HH; Chung AYF; Ooi LLPJ; Chang JPE; Tan CK; Lee CGL
Sci Rep; 2019 Jul; 9(1):10464. PubMed ID: 31320713
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs, miR-939, miR-595, miR-519d and miR-494, Identify Cirrhotic Patients with HCC.
Fornari F; Ferracin M; Trerè D; Milazzo M; Marinelli S; Galassi M; Venerandi L; Pollutri D; Patrizi C; Borghi A; Foschi FG; Stefanini GF; Negrini M; Bolondi L; Gramantieri L
PLoS One; 2015; 10(10):e0141448. PubMed ID: 26509672
[TBL] [Abstract][Full Text] [Related]
9. Next generation sequencing reveals microRNA isoforms in liver cirrhosis and hepatocellular carcinoma.
Wojcicka A; Swierniak M; Kornasiewicz O; Gierlikowski W; Maciag M; Kolanowska M; Kotlarek M; Gornicka B; Koperski L; Niewinski G; Krawczyk M; Jazdzewski K
Int J Biochem Cell Biol; 2014 Aug; 53():208-17. PubMed ID: 24875649
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma.
Lendvai G; Szekerczés T; Gyöngyösi B; Schlachter K; Kontsek E; Pesti A; Patonai A; Werling K; Kovalszky I; Schaff Z; Kiss A
Pathol Oncol Res; 2019 Jul; 25(3):1103-1109. PubMed ID: 30411298
[TBL] [Abstract][Full Text] [Related]
11. miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
Fittipaldi S; Vasuri F; Bonora S; Degiovanni A; Santandrea G; Cucchetti A; Gramantieri L; Bolondi L; D'Errico A
Dig Dis Sci; 2017 Sep; 62(9):2397-2407. PubMed ID: 28639131
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients.
Ashmawy AM; Elgeshy KM; Abdel Salam ET; Ghareeb M; Kobaisi MH; Amin HAA; Sharawy SK; Abdel Wahab AHA
Arab J Gastroenterol; 2017 Sep; 18(3):144-150. PubMed ID: 28958640
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-224 Expression and Polymorphism Predict the Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Liver Resection.
Wu C; Wang X; Zhang J; Tang G; Xu Y; Lu C; Li Y
Clin Lab; 2019 Jun; 65(6):. PubMed ID: 31232017
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
15. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
Zhang R; Jiang YY; Xiao K; Huang XQ; Wang J; Chen SY
J Cancer Res Clin Oncol; 2020 Jan; 146(1):87-96. PubMed ID: 31758243
[TBL] [Abstract][Full Text] [Related]
16. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
17. Correlation of microRNA-16, microRNA-21 and microRNA-101 expression with cyclooxygenase-2 expression and angiogenic factors in cirrhotic and noncirrhotic human hepatocellular carcinoma.
Zeng W; van den Berg A; Huitema S; Gouw AS; Molema G; de Jong KP
PLoS One; 2014; 9(4):e95826. PubMed ID: 24759835
[TBL] [Abstract][Full Text] [Related]
18. Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers.
Liu X; Wang SK; Zhang K; Zhang H; Pan Q; Liu Z; Pan H; Xue L; Yen Y; Chu PG
Carcinogenesis; 2015 Feb; 36(2):232-42. PubMed ID: 25542894
[TBL] [Abstract][Full Text] [Related]
19. miR-27a as an oncogenic microRNA of hepatitis B virus- related hepatocellular carcinoma.
Wu XJ; Li Y; Liu D; Zhao LD; Bai B; Xue MH
Asian Pac J Cancer Prev; 2013; 14(2):885-9. PubMed ID: 23621256
[TBL] [Abstract][Full Text] [Related]
20. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
